- Investing Ideas
- U.K. Pharmaceuticals & Biotech High Growth Potential Companies
U.K. Pharmaceuticals & Biotech High Growth Potential Companies
Results
6
Companies with a Future performance score of at least 3, ordered by Future performance score.
6 companies
Oxford Biomedica
Market Cap: UK£775.0m
A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.
OXB
UK£6.41
7D
12.1%
1Y
114.4%
Diaceutics
Market Cap: UK£139.3m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.65
7D
-0.9%
1Y
36.0%
Shield Therapeutics
Market Cap: UK£99.9m
A commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs.
STX
UK£0.093
7D
-0.5%
1Y
297.9%
AstraZeneca
Market Cap: UK£234.5b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£151.18
7D
0.9%
1Y
49.3%
Animalcare Group
Market Cap: UK£229.9m
Develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets.
ANCR
UK£3.33
7D
35.4%
1Y
47.3%
hVIVO
Market Cap: UK£67.3m
Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.
HVO
UK£0.098
7D
32.4%
1Y
-39.7%